It is important to note that in our analysis, if using gene mutation data alone, none of the genes in the positively regulating FFL would have been identified, since the mutation frequency of PDGF-D, FLT1, and SHC1 are very low across all breast cancer samples. The gene discussed is PDGFD; the disease is breast carcinoma.